Akebia Therapeutics
AKBA
#8295
Rank
A$0.41 B
Marketcap
A$1.56
Share price
1.87%
Change (1 day)
-72.23%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: A$0.41 Billion

As of June 2026 Akebia Therapeutics has a market cap of A$0.41 Billion. This makes Akebia Therapeutics the world's 8295th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.41 B-36.34%
2025A$0.65 B-3.85%
2024A$0.68 B99.49%
2023A$0.34 B119.82%
2022A$0.15 B-71.4%
2021A$0.54 B3.63%
2020A$0.52 B-52.08%
2019A$1.09 B19.7%
2018A$0.91 B1.91%
2017A$0.90 B62.67%
2016A$0.55 B1.78%
2015A$0.54 B87.69%
2014A$0.28 B

End of Day market cap according to different sources

On Jun 22nd, 2026 the market cap of Akebia Therapeutics was reported to be:

A$0.41 Billion
by Nasdaq info icon info icon
A$0.41 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$797.17 B 190,311.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$406.87 B 97,085.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
A$266.38 B 63,527.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$3.17 B 659.14%๐Ÿ‡บ๐Ÿ‡ธ USA